Improved and optimized drug repurposing for the SARS-CoV-2 pandemic.

Improved and optimized drug repurposing for the SARS-CoV-2 pandemic.

The active global SARS-CoV-2 pandemic caused more than 426 million cases and 5.8 million deaths worldwide. The development of completely new drugs for such a novel disease is a challenging, time intensive process. Despite researchers around the world working on this task, no effective treatments hav...

Full description

Bibliographic Details
Main Authors: Sarel Cohen, Moshik Hershcovitch, Martin Taraz, Otto Kißig, Davis Issac, Andrew Wood, Daniel Waddington, Peter Chin, Tobias Friedrich
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0266572

Internet

https://doi.org/10.1371/journal.pone.0266572

Similar Items